CLGNNasdaqOrthopedic, Prosthetic & Surgical Appliances & SuppliesFiscal year ends December 31
CollPlant Biotechnologies Ltd
Financials through fiscal 2025, year ended Dec 31, 2025Last filing: 20-F on Mar 26, 2026
$3.56−0.06 (-1.79%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
CollPlant Biotechnologies Ltd revenue by segment
By business segment
By product or service
| Revenue | Q2 25 | Q2 24 | Q2 23 | Q2 22 | Q2 21 | Q2 20 | Q2 19 | Q2 18 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenues from the Sales of Goods [Member] | $179.00K | $249.00K | $184.00K | – | – | – | – | – | 100.0% | -28.1% |
| Revenues from milestones [Member] | – | – | $10.00M | – | – | – | – | – | – | – |
By region
| Revenue | Q2 25 | Q2 24 | Q2 23 | Q2 22 | Q2 21 | Q2 20 | Q2 19 | Q2 18 | % of revenue | YoY |
|---|---|---|---|---|---|---|---|---|---|---|
| North America [Member] | $159.00K | $244.00K | – | – | – | – | – | – | 88.8% | -34.8% |
| Europe and others [Member] | $20.00K | $5.00K | $23.00K | – | – | – | – | – | 11.2% | +300.0% |
| Europe and others [Member] | – | – | $23.00K | $25.00K | $498.00K | $34.00K | $53.00K | $51.00K | – | – |
| United states and Canada [Member] | – | $244.00K | $10.16M | – | – | – | $553.00K | $131.00K | – | – |
| United States | – | – | $10.16M | $41.00K | $193.00K | $789.00K | $553.00K | – | – | – |
| Total [Member] | – | – | $10.18M | $66.00K | $691.00K | $823.00K | – | – | – | – |
From the segment and revenue-disaggregation notes of CollPlant Biotechnologies's 10-K and 10-Q filings (XBRL). Fourth-quarter figures are the fiscal year less the first nine months. Segment names follow the company's own labels and can change when it reorganizes.